Is Igc Pharma Stock a good buy in 2025, according to Wall Street analysts?
The consensus among 2 Wall Street analysts covering (NYSEMKT: IGC) stock is to Strong Buy IGC stock.
Out of 2 analysts, 1 (50%) are recommending IGC as a Strong Buy, 1 (50%) are recommending IGC as a Buy, 0 (0%) are recommending IGC as a Hold, 0 (0%) are recommending IGC as a Sell, and 0 (0%) are recommending IGC as a Strong Sell.
According to 2 Wall Street analysts that have issued a 1 year IGC price target, the average IGC price target is $3.88, with the highest IGC stock price forecast at $4.25 and the lowest IGC stock price forecast at $3.50.
On average, Wall Street analysts predict that Igc Pharma's share price could reach $3.88 by Mar 6, 2026. The average Igc Pharma stock price prediction forecasts a potential upside of 1,269.26% from the current IGC share price of $0.28.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.